These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 508012)

  • 1. Protective effect of cetraxate, a new antiulcer drug, against serotonin-induced ulcer.
    Hashizume T; Aibara S; Hirokawa K; Nishida A; Ogawa H; Kasahara A
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):314-27. PubMed ID: 508012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and histological studies of gastric mucosal lesion induced by serotonin in rats.
    Hashizume T; Hirokawa K; Aibara S; Ogawa H; Kasahara A
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):96-108. PubMed ID: 747467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gastrointestinal and autonomic effects of 3-methyl-5,6,7,8-tetrahydroquinoline-8-thiocarboxamide hydrochloride (tiquinamide).
    Beattie DE; Dixon GT; Waterfall JF; Alps BJ
    Arzneimittelforschung; 1979; 29(10):1564-9. PubMed ID: 583223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride on gastric mucosal blood flow.
    Hoshina K; Okada N; Inoue K; Yamamoto M; Saito N; Takeshita T; Naruchi T
    Arzneimittelforschung; 1987 Nov; 37(11):1284-9. PubMed ID: 3440037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
    Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
    Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of prolonged oral administration of cetraxate hydrochloride on experimentally-induced intestinal metaplasia in Wistar rats.
    Tatsuta M; Yamamura H; Iishi H; Taniguchi H
    Arzneimittelforschung; 1987 Sep; 37(9):1045-8. PubMed ID: 3435599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103).
    Hoshina K; Yamazaki N; Takeshita T; Naruchi T
    Arzneimittelforschung; 1985; 35(2):493-7. PubMed ID: 3873243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of alpha2-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence.
    Fülöp K; Zádori Z; Rónai AZ; Gyires K
    Eur J Pharmacol; 2005 Dec; 528(1-3):150-7. PubMed ID: 16313902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric anti-ulcer and cytoprotective properties of 2-(3,4-dimethoxyphenyl)-5-methyl-thiazolidine-4-one in rat experimental ulcers.
    Matsuo Y; Kuwayama H; Itoh H; Seki A; Fukuda S; Kawasaki T; Hotta T; Ohsaka Y; Komatsu K
    Arzneimittelforschung; 1986 Aug; 36(8):1236-40. PubMed ID: 3778561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing effect of sodium 3-ethyl-7-isopropyl-1-azulenesulfonate 1/3 hydrate (KT1-32), a novel antiulcer agent, on gastric mucosal blood flow in anesthetized.
    Yano S; Horie S; Wakabayashi S; Mochizuki S; Tomiyama A; Watanabe K
    Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):253-6. PubMed ID: 2277867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiulcer activity of an anthocyanidin from Vaccinium myrtillus.
    Magistretti MJ; Conti M; Cristoni A
    Arzneimittelforschung; 1988 May; 38(5):686-90. PubMed ID: 3415709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of the anti-ulcer drug SU-88 on the gastric blood flow and the cardiovascular system (author's transl)].
    Saziki R; Arai I; Isobe Y; Aihara H
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):193-202. PubMed ID: 7084818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
    DiJoseph JF; Eash JR; Mir GN
    J Pharmacol Exp Ther; 1987 Apr; 241(1):97-102. PubMed ID: 2883297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats.
    Yamasaki K; Ishiyama H; Imaizumi T; Kanbe T; Yabuuchi Y
    Jpn J Pharmacol; 1989 Apr; 49(4):441-8. PubMed ID: 2542684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of puerarin on stress-induced gastric mucosal injury in rats].
    Wang FW; Li J; Hu ZL; Xie YY
    Zhongguo Zhong Yao Za Zhi; 2006 Mar; 31(6):504-6. PubMed ID: 16722386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoprotective action of cetraxate against HCl.ethanol-induced gastric lesion in rats.
    Kurebayashi Y; Ikeda T; Osada Y
    Jpn J Pharmacol; 1988 Jan; 46(1):17-25. PubMed ID: 3367546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1-induced gastric ulcer is attenuated by cetraxate.
    Lazaratos S; Kashimura H; Nakahara A; Fukutomi H; Osuga T; Miyauchi T; Goto K
    Life Sci; 1993; 53(7):PL123-8. PubMed ID: 8350665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the damaging effects of acetazolamide on gastric mucosa in rats.
    Cho CH; Pfeiffer CJ
    Acta Physiol Hung; 1984; 64(3-4):279-85. PubMed ID: 6442531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intraperitoneal effects of 5-hydroxytryptamine on haemodynamics, gastric mucosal blood flow and platelet aggregation.
    Cho CH; Mei QB; Kaan SK
    Eur J Pharmacol; 1994 Apr; 256(1):9-15. PubMed ID: 8026564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of water immersion stress-induced gastric lesions through the enhancement of nitric oxide synthase activity in rats.
    Tachi K; Goto H; Hayakawa T; Sugiyama S
    Aliment Pharmacol Ther; 1996 Feb; 10(1):97-103. PubMed ID: 8871449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.